Cargando…
Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla
Type 2 diabetes mellitus (T2DM) is a complex, chronic and progressive metabolic disease, which is characterized by relative insulin deficiency, insulin resistance, and high glucose levels in blood. Esteemed published articles and epidemiological data exhibit an increased risk of developing Alzheimer...
Autores principales: | Markowicz-Piasecka, Magdalena, Sikora, Joanna, Szydłowska, Aleksandra, Skupień, Agata, Mikiciuk-Olasik, Elżbieta, Huttunen, Kristiina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736777/ https://www.ncbi.nlm.nih.gov/pubmed/28589443 http://dx.doi.org/10.1007/s11095-017-2199-y |
Ejemplares similares
-
Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2017) -
Biocompatibility Studies of Gadolinium Complexes with Iminodiacetic Acid Derivatives
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2018) -
Extract of Aronia melanocarpa-modified hemostasis: in vitro studies
por: Sikora, Joanna, et al.
Publicado: (2014) -
Synthesis and Biocompatibility Studies of New Iminodiacetic Acid Derivatives
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2017) -
Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2018)